Core Viewpoint - Agricultural Bank of China is facing legal issues due to allegations of mis-selling a high-risk fund, leading to significant losses for a customer [2][20]. Group 1: Fund Mis-selling Incident - A customer, Ms. Li, claims that in July 2021, she was persuaded by a bank employee to deposit 10 million yuan into the bank under the pretense of a safe investment, which was later used to purchase a high-risk fund named "Oriental Quality Consumption One-Year Holding Period Mixed A" [2][20]. - As of November 2024, this fund has incurred losses exceeding 5.79 million yuan, and Ms. Li alleges that the bank failed to fulfill its risk disclosure obligations [20]. - The court dismissed Ms. Li's lawsuit, stating that she had signed multiple risk disclosure documents and had sufficient investment experience to understand the risks involved [20]. Group 2: Fund Performance and Fees - The "Oriental Quality Consumption One-Year Holding Period Mixed A" fund, established on July 8, 2021, has seen its net asset size decline from 3.5 billion yuan at inception to 630 million yuan by the end of 2025, with a cumulative loss of over 63% since its establishment [3][22]. - Agricultural Bank has collected a total of 1.526 million yuan in custody fees for this fund over four years, with an annual custody fee rate of 0.20% [21][25]. - The fund's management fees are set at 1.20% per year, and it has not distributed any dividends since its inception [22][23]. Group 3: Agricultural Bank's Wealth Management and Fund Custody - As of the end of 2025, Agricultural Bank's public fund custody scale has surpassed 2 trillion yuan, ranking it among the top ten fund sales institutions in China [11][30]. - The bank's net income from fees and commissions reached 51.441 billion yuan in the first half of 2025, marking a year-on-year increase of 10.1%, with a significant rise in agency business income by 62.3% [33][34]. - The bank emphasizes the importance of compliance in fund custody and sales to ensure sustainable development amid ongoing wealth management business transformation [35].

Core Viewpoint - On March 23, the Industrial and Commercial Bank of China (ICBC) executed a block trade involving 2.4 million shares, with a total transaction value of 17.4 million yuan, representing 0.47% of the total trading volume for the day, at a price of 7.25 yuan per share, which was consistent with the market closing price [1]. Group 1 - The block trade involved 2.4 million shares of ICBC [1] - The total transaction amount was 17.4 million yuan [1] - The transaction price was 7.25 yuan, unchanged from the market closing price [1]

Core Viewpoint - The company has engaged in structured deposits with banks, resulting in significant returns over the past year [1] Group 1: Structured Deposits - In June 2025, the company subscribed to structured deposits worth 1 billion yuan with the Shenzhen Qianhai branch of Bank of Communications [1] - In January 2026, the company made two additional subscriptions of 500 million yuan each with the Shenzhen Technology branch of Jiangsu Bank [1] - Recently, the company redeemed all structured deposits, retrieving a total principal of 2 billion yuan and earning a profit of 19.25 million yuan [1] Group 2: Financial Performance - Over the last 12 months, the company invested a total of 4.8 billion yuan in structured deposits and recovered 4.2 billion yuan, yielding a total profit of 41.53 million yuan [1] - The company has 600 million yuan in principal that has not yet been recovered from structured deposits [1] - The company has fully recovered 5.04 billion yuan from seven-day notice deposits, generating a profit of 6.44 million yuan [1]

Core Viewpoint - UBS forecasts that the price of thermal coal in China will be between 750 to 800 RMB per ton for the full year of 2026, with price increases expected during the summer replenishment window in May and June, influenced by high international energy prices and fluctuations in Indonesian supply [2] Price Forecast - The projected prices for QHD5500 coal from 2026 to 2028 are 750 RMB, 720 RMB, and 670 RMB per ton, reflecting a tightening global energy market and slight impacts from Indonesia's quota reductions [2] Company Ratings - China Shenhua (601088.SH) and China Shenhua (01088) have target prices set at 48.6 RMB and 48 HKD respectively, with a "Neutral" rating [2] - Yanzhou Coal Mining (01171) has a target price of 11.4 HKD, and Shaanxi Coal and Chemical Industry (601225.SH) has a target price of 22.8 RMB, both maintaining a "Sell" rating due to current stock prices exceeding fundamental valuations [2]

Core Viewpoint - China Coal Energy recently indicated that the thermal coal market is showing a steady yet slightly strong trend due to various factors including decreased load at end-user power plants, reduced coal supply, and low port inventories [1] Group 1: Market Performance - In February, the price of 5500 kcal thermal coal at ports reached 748 RMB/ton, an increase of 52 RMB/ton, or 7.5% month-on-month, and a year-on-year increase of 6.7% [1] Group 2: Future Outlook - In March, the thermal coal market is expected to exhibit an overall balanced and narrow fluctuation trend due to ongoing geopolitical tensions, weak overall coal demand, slow recovery of domestic supply, and a slight rebound in port inventories [1] - The expected price fluctuation range for port thermal coal spot prices is between 720 and 760 RMB/ton [1]

Summary of Key Points Core Viewpoint - On March 23, BYD executed a block trade of 112,000 shares, with a transaction value of 12.05 million yuan, representing 0.06% of the total trading volume for the day, at a price of 107.63 yuan, which was consistent with the market closing price [1][2]. Group 1: Transaction Details - The block trade on March 23 involved a total of 112,000 shares of BYD, with a total transaction value of 12.05 million yuan [1][2]. - The transaction price was 107.63 yuan per share, which was equal to the market closing price on that day [1][2]. - The trading volume included two separate transactions: one for 42,000 shares valued at 4.52 million yuan and another for 70,000 shares valued at 7.53 million yuan [3]. Group 2: Trading Parties - The buyer for both transactions was an institutional entity, while the seller was identified as Guotai Junan Securities Co., Ltd., with specific branches involved in the trades [3].

Core Insights - Huawei launched the upgraded versions of the Zhijie R7 and new S7 during its Spring All-Scenario Product Launch on March 23 [1] - The first batch of 896 line dual-light path image-level lidar Zhijie Dual 7 vehicles was officially delivered in seven cities including Beijing, Shanghai, Shenzhen, Nanjing, Hefei, Hangzhou, and Changsha [1] - Zhao Changjiang, a veteran from BYD and currently the Executive Director and Executive Vice President of Zhijie, was present at the delivery event in Changsha to hand over the new vehicles to the first batch of owners [1]

Core Viewpoint - The announcement indicates that the company's subsidiary has received approval for the production of Ibuprofen granules, which are included in the national medical insurance drug list for 2025, suggesting a significant market opportunity in the pharmaceutical sector [1] Company Summary - The company, through its wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical Co., Ltd., has obtained the drug registration certificate for Ibuprofen granules from the National Medical Products Administration [1] - The approval of Ibuprofen granules positions the company to capitalize on the growing demand for this medication in the Chinese market [1] Industry Summary - Ibuprofen granules are classified as a Category B drug in the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List for 2025 [1] - The estimated sales revenue for Ibuprofen-related formulations in Chinese public medical institutions is approximately RMB 4.4 billion in 2024, indicating a substantial market size and potential for growth [1]

转自：智通财经 【荣昌生物：维迪西妥单抗新增乳腺癌适应症获批】《科创板日报》23日讯，荣昌生物(688331.SH)公 告称，公司自主研发的注射用维迪西妥单抗(商品名：爱地希®)用于治疗HER2低表达且存在肝转移的乳 腺癌新适应症获国家药监局批准，成为该药在国内获批的第四项适应症。该适应症适用于既往接受过系 统治疗或辅助化疗后12个月内复发的不可切除或转移性HER2低表达成人乳腺癌患者。此次获批基于一 项Ⅲ期临床试验，结果显示其在目标人群中具有良好疗效与安全性。公司提示，药品商业化受政策、市 场及竞争等多重因素影响，存在不确定性。 ...

Core Viewpoint - Canon has launched the "EOS Starry Peach Blossom Festival" in Linzhi, Tibet, integrating professional imaging technology with the region's unique highland scenery, aiming to create a platform for photography and cultural tourism [3]. Group 1: Event Overview - The "EOS Starry Peach Blossom Festival" officially commenced on March 21, 2026, coinciding with the 23rd Peach Blossom Tourism and Culture Festival in Linzhi [3]. - The event features the establishment of the "EOS Scenic Imaging Creation Base" in Gala Peach Blossom Village, serving as a long-term bridge connecting professional photographers and photography enthusiasts with Linzhi's stunning landscapes [5]. Group 2: Photography Activities - During the festival, Canon has organized a nationwide landscape photography contest from March 20 to April 20, encouraging participants to capture the beauty of Linzhi's peach blossoms and snow-capped mountains, with prizes including the Canon RF15-30mm F4.5-6.3 IS STM lens and tickets to four popular scenic spots in Linzhi [7]. Group 3: Equipment and Techniques - Canon's EOS R5 II and RF24-105mm F4L IS USM lens are highlighted as versatile tools for landscape photography, capable of capturing both expansive scenes and intricate details [8]. - The new RF7-14mm F2.8-3.5 L FISHEYE STM and RF14mm F1.4 L VCM ultra-wide-angle lenses are specifically designed for capturing the festival's unique starry and floral landscapes [20][27]. Group 4: Visual Experience - The festival showcases the breathtaking combination of snow-capped mountains, flower seas, and starry skies, with Canon's EOS R system effectively capturing this unique scenery [26].